Proteinase-activated receptor 1 antagonism ameliorates experimental pulmonary hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proteinase-activated receptor 1 antagonism ameliorates experimental pulmonary hypertension

Published:2018-11-13 Issue:8 Volume:115 Page:1357-1368
ISSN:0008-6363
Container-title:Cardiovascular Research
language:en
Short-container-title:

Author:

Kuwabara Yukimitsu¹²,Tanaka-Ishikawa Mariko²³,Abe Kohtaro²,Hirano Mayumi¹,Hirooka Yoshitaka⁴,Tsutsui Hiroyuki²,Sunagawa Kenji²,Hirano Katsuya⁵

Affiliation:

1. Department of Molecular Cardiology, Research Institute of Angiocardiology, Graduate School of Medicine, Kyushu University, Fukuoka, Japan

2. Department of Cardiovascular Medicine, Research Institute of Angiocardiology, Graduate School of Medicine, Kyushu University, Fukuoka, Japan

3. Department of Anesthesiology and Critical Care, Graduate School of Medicine, Kyushu University, Fukuoka, Japan

4. Department of Advanced Cardiovascular Regulation and Therapeutics, Graduate School of Medicine, Kyushu University, Fukuoka, Japan

5. Department of Cardiovascular Physiology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, Japan

Funder

JSPS

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://academic.oup.com/cardiovascres/article-pdf/115/8/1357/28852675/cvy284.pdf

Reference42 articles.

1. Treatment of pulmonary arterial hypertension with targeted therapies;O'Callaghan;Nat Rev Cardiol,2011

2. Thrombotic arteriopathy and anticoagulation in pulmonary hypertension;Johnson;Chest,2006

3. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension;Eisenberg;Circulation,1990

4. Calibrated automated thrombography demonstrates hypercoagulability in patients with idiopathic pulmonary arterial hypertension;Tournier;Thromb Res,2010

5. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA);Olsson;Circulation,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-Cell Analysis Reveals Distinct Immune and Smooth Muscle Cell Populations that Contribute to Chronic Thromboembolic Pulmonary Hypertension;American Journal of Respiratory and Critical Care Medicine;2023-05-15

2. A current overview of RhoA, RhoB, and RhoC functions in vascular biology and pathology;Biochemical Pharmacology;2022-12

3. Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity;Frontiers in Immunology;2022-09-27

4. Puerarin-V prevents the progression of hypoxia- and monocrotaline-induced pulmonary hypertension in rodent models;Acta Pharmacologica Sinica;2022-02-21

5. Coagulation-independent effects of thrombin and Factor Xa: role of protease-activated receptors in pulmonary hypertension;Cardiovascular Research;2022-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3